InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Discover the full record of transactions filed by Remmel H. Lawrence, Director. Director active across 1 company, notably Atossa Therapeutics, INC.. Cumulatively, 2 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 26 March 2025. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Remmel H. Lawrence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares0Common StockSEC:0001193125-26-224140:0
10,000 shares@ US$0.70100.0% of flowCommon StockSEC:0000950170-25-046742:0
Canonical exit: 24 Jun 2025 (T+90)
2 of 2 declarations
About Remmel H. Lawrence
Lawrence H. Remmel is a Director at ATOSSA THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset to the board of directors. He plays a key role in the future direction of ATOSSA.
